Fractional laser and low-level light combination therapy in patients with recalcitrant alopecia areata
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and ObjectivesThe current treatment options for alopecia areata (AA) typically aim to suppress inflammatory T-cell responses. Patients vary in their response to these treatments, and some do not respond to one or more types of therapy. Herein, we report the outcomes of combination therapy, employing fractional laser treatment and low-level light therapy (LLLT), with a focus on patients with recalcitrant AA.Materials and MethodsLLLT (HEALITE II®; Lutronic, Goyang, Republic of Korea) and fractional laser treat ment (StarluxTM 1540; Palomar Medical Technologies Inc., Burlington, MA, USA) were administered to the subjects every two weeks. Two dermatologists independently compared photographs taken at baseline and final follow-up visits and assessed the level of hair regrowth using a 5-point scale. The scale levels and their description are as follows: 0, no improvement; 1, < 25% (slight improvement); 2, 25%-50% (moderate improvement); 3, 50%-75% (marked improvement); and 4, 75%-100% (most improvement).ResultsTwenty patients (13 males and 7 females) were evaluated in this study. The mean improvement level was 2.55 points with 55% (n = 11) of patients showing > 50% improvement. No serious adverse events occurred, and treatment cessation was never deemed necessary.ConclusionBased on the results of this study, we propose that combination therapy may represent a viable new approach for the treatment of recalcitrant AA.
Abstract
Background and ObjectivesThe current treatment options for alopecia areata (AA) typically aim to suppress inflammatory T-cell responses. Patients vary in their response to these treatments, and some do not respond to one or more types of therapy. Herein, we report the outcomes of combination therapy, employing fractional laser treatment and low-level light therapy (LLLT), with a focus on patients with recalcitrant AA.Materials and MethodsLLLT (HEALITE II®; Lutronic, Goyang, Republic of Korea) and fractional laser treat ment (StarluxTM 1540; Palomar Medical Technologies Inc., Burlington, MA, USA) were administered to the subjects every two weeks. Two dermatologists independently compared photographs taken at baseline and final follow-up visits and assessed the level of hair regrowth using a 5-point scale. The scale levels and their description are as follows: 0, no improvement; 1, < 25% (slight improvement); 2, 25%-50% (moderate improvement); 3, 50%-75% (marked improvement); and 4, 75%-100% (most improvement).ResultsTwenty patients (13 males and 7 females) were evaluated in this study. The mean improvement level was 2.55 points with 55% (n = 11) of patients showing > 50% improvement. No serious adverse events occurred, and treatment cessation was never deemed necessary.ConclusionBased on the results of this study, we propose that combination therapy may represent a viable new approach for the treatment of recalcitrant AA.
참고문헌 (30)
- Shapiro J, "Current treatment of alopecia areata", J Investig Dermatol Symp Proc, 16, pp.S42~S44 (2013)
- Trüeb RM, "Alopecia areata : a comprehensive review of pathogenesis and management", Clin Rev Allergy Immunol, 54, pp.68~87 (2018)
- Cranwell WC, "Treatment of alopecia areata : an Australian expert consensus statement", Australas J Dermatol, 60, pp.163~170 (2019)
- 여인권, "Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata", Annals of Dermatology, 27(6), pp.676~681 (2015), 대한피부과학회
- Herz-Ruelas ME, "Immunotherapy for resistant and", or severe alopecia areata in a university hospital setting in Northern Mexico, 2020, pp.61, e137~e139
- Mascia P, "Azathioprine in combination with methotrexate : a therapeutic alternative in severe and recalcitrant forms of alopecia areata?", J Eur Acad Dermatol Venereol, 33, pp.e494~e495 (2019)
- 임슬기, "Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata", Annals of Dermatology, 29(3), pp.263~267 (2017), 대한피부과학회
- 최중운, "Simvastatin", Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients, 2017, pp.29(6), 755~760[DOI]
- Gupta AK, "Treating alopecia areata : current practices versus new directions", Am J Clin Dermatol, 18, pp.67~75 (2017)
- Darwin E, "A review of monochromatic light devices for the treatment of alopecia areata", Lasers Med Sci, 33, pp.435~444 (2018)
- Lee JH, "A novel 311-nm Titanium : Sapphire laser therapy for alopecia areata : a pilot study of 19 patients", Lasers Med Sci, 35, pp.999~1002 (2020)
- Al Hamzawi NK, "Evaluation of the efficacy and safety of 308-nm monochromatic excimer lamp in the treatment of resistant alopecia areata", Int J Trichology, 11, pp.199~206 (2019)
- Gupta AK, "Meta-analysis of 308-nm excimer laser therapy for alopecia areata", J Dermatolog Treat, 32, pp.526~529 (2021)
- Arakawa Y, "Three hundred and eight nanometer excimer light therapy for alopecia universalis that is resistant to other treatments : a clinical study of 11 patients", J Dermatol, 43, pp.1412~1416 (2016)
- Welsh O, "Phototherapy for alopecia areata", Clin Dermatol, 34, pp.628~632 (2016)
- Marchitto MC, "Emerging nonsteroid-based procedural therapies for alopecia areata : a systematic review", Dermatol Surg, 45, pp.1484~1506 (2019)
- Yoo KH, "Treatment of alopecia areata with fractional photothermolysis laser", Int J Dermatol, 49, pp.845~847 (2010)
- Yoo KH, "Photodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetration", Dermatol Surg, 36, pp.618~622 (2010)
- Lee JW, "Photodynamic therapy with methyl 5-aminolevulinate acid combined with microneedle treatment in patients with extensive alopecia areata", Clin Exp Dermatol, 35, pp.548~549 (2010)
- Tsai YC, "Alopecia areata treated with fractional photothermolysis laser : a case report", J Am Acad Dermatol, 74(5 Suppl 1), pp.AB132~ (2016)
- Majid I, "Fractional carbon dioxide laser in combination with topical corticosteroid application in resistant alopecia areata : a case series", J Cutan Aesthet Surg, 11, pp.217~221 (2018)
- Dabek RJ, "Fractional laser-assisted hair regrowth and microneedling for the treatment of alopecia areata : a review", Cureus, 11, pp.e4943~ (2019)
- Perper M, "Efficacy of fractional lasers in treating alopecia : a literature review", Lasers Med Sci, 32, pp.1919~1925 (2017)
- Al-Dhalimi MA, "The use of a 1, 540 nm fractional erbium-glass laser in treatment of alopecia areata", Lasers Surg Med, 51, pp.859~865 (2019)
- Wang W, "Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil", J Cosmet Dermatol, 18, pp.1009~1013 (2019)
- Hamblin MR, "Photobiomodulation for the management of alopecia : mechanisms of action, patient selection and perspectives", Clin Cosmet Investig Dermatol, 12, pp.669~678 (2019)
- Zarei M, "Low level laser therapy and hair regrowth : an evidence-based review", Lasers Med Sci, 31, pp.363~371 (2016)
- Mihu CM, "Minoxidil and neoptide topical application reinforced by low-level laser therapy on an animal model of alopecia", Stud Univ Babes-Bolyai Chem, 60, pp.295~308 (2015)
- Mlacker S, "A review on laser and light-based therapies for alopecia areata", J Cosmet Laser Ther, 19, pp.93~99 (2017)
- Bae JM, "Hair regrowth through wound healing process after ablative fractional laser treatment in a murine model", Lasers Surg Med, 47, pp.433~440 (2015)